• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

DACH

Paragon-backed Apontis Pharma sets IPO price range
Paragon-backed Apontis Pharma sets IPO price range

Shares are priced at €18.5-24.5, with a final pricing expected on 6 May before the 11 May listing

  • DACH
  • 30 April 2021
Tikehau's SPAC Pegasus raises €500m
Tikehau's SPAC Pegasus raises €500m

Tikehau, FinanciУЈre Agache, Jean-Pierre Mustier and Diego De Giorgi commit to invest a total amount in excess of т‚Ќ165m

  • Investments
  • 30 April 2021
Ares closes Ares Capital Europe V on €11bn
Ares closes Ares Capital Europe V on €11bn

Ace V is Ares' largest institutional fund yet and is 70% larger than its т‚Ќ6.5bn predecessor

  • Debt
  • 29 April 2021
Capza closes fifth debt fund on €1.6bn, prepares new launch
Capza closes fifth debt fund on €1.6bn, prepares new launch

Fund invests in SMEs with EBITDA of more than €12m, providing unitranche and mezzanine

  • Funds
  • 29 April 2021
VCs in $75m round for Kaia Health
VCs in $75m round for Kaia Health

Digital physical therapy platform is backed by all existing investors, including Balderton Capital

  • Expansion
  • 29 April 2021
Endeit Capital holds final close for third fund on €250m
Endeit Capital holds final close for third fund on €250m

Fund II closed on т‚Ќ125m in 2016; Fund III will continue to invest scale-up capital in European startups

  • Venture
  • 28 April 2021
Corten buys Emeram's Matrix42
Corten buys Emeram's Matrix42

SBO of the digital workspace software is Corten's first investment from its €392m debut fund

  • Buyouts
  • 28 April 2021
Gilde Healthcare buys Acti-Med
Gilde Healthcare buys Acti-Med

Deal is the fourth platform investment from the GP's €200m Gilde Healthcare Services III fund

  • Buyouts
  • 28 April 2021
Capiton, Nord Holding sell Engelmann Sensor to DPE
Capiton, Nord Holding sell Engelmann Sensor to DPE

Smart meter business is the final portfolio company in Capiton's 2010-vintage fourth fund

  • Exits
  • 27 April 2021
Telemos Capital acquires Mammut
Telemos Capital acquires Mammut

Conzzeta began to explore sale options for the Swiss outdoor clothing and hardware brand in 2019

  • Buyouts
  • 27 April 2021
Maguar Capital invests in Bregal-backed STP
Maguar Capital invests in Bregal-backed STP

Maguar partner Gunther Thies founded STP; partner Arno Poschik was on STP's board during his time at Hg

  • Buyouts
  • 27 April 2021
Appetite for DACH tech deals continues apace in Q1
Appetite for DACH tech deals continues apace in Q1

Sponsor demand for differentiated IT services and roll-up strategies remains consistent

  • DACH
  • 27 April 2021
KKR sells minority stake in Hensoldt
KKR sells minority stake in Hensoldt

Leonardo is to buy the 25.1% stake for €606m; KKR will retain an 18% stake in the sensor developer

  • Exits
  • 26 April 2021
EQT's Suse sets out IPO plans
EQT's Suse sets out IPO plans

Enterprise software platform intends to generate net proceeds of $500m with its Q2 2021 IPO

  • Investments
  • 26 April 2021
Finexx buys Volpini Verpackungen
Finexx buys Volpini Verpackungen

GP also announces it has increased the volume of its Finexx II fund to €30m

  • Buyouts
  • 23 April 2021
Digital Alpha Fund II closes on $1bn
Digital Alpha Fund II closes on $1bn

Fund invests in digital assets, with a focus on next-gen networks, cloud computing and "smart cities"

  • Funds
  • 23 April 2021
DACH buyouts continue recovery from Q2 2020 low
DACH buyouts continue recovery from Q2 2020 low

Both deal volume and value are now back on par with the figures for Q4 2019, prior to the pandemic

  • Data Snapshot
  • 23 April 2021
Columbus Life Sciences Fund III closes on €120m
Columbus Life Sciences Fund III closes on €120m

Fund invests in early-stage and high-growth opportunities across the life sciences and pharmaceutical industries

  • Funds
  • 23 April 2021
Paragon acquires Bregal's Sovendus
Paragon acquires Bregal's Sovendus

Bregal acquired a minority stake in the e-commerce customer reward platform in 2015

  • Buyouts
  • 22 April 2021
AlpInvest Co-Investment Fund VIII closes on $3.5bn
AlpInvest Co-Investment Fund VIII closes on $3.5bn

ACF VIII invests alongside GPs in private equity buyouts and growth capital transactions across a variety of sectors

  • Funds
  • 22 April 2021
SHS sells stake in Medigroba to trade
SHS sells stake in Medigroba to trade

Medical homecare provider Medigroba received significant inbound interest from strategic buyers

  • Exits
  • 22 April 2021
Endeavour Vision closes Medtech Growth II on $375m
Endeavour Vision closes Medtech Growth II on $375m

Fund is 30% larger than its predecessor and will continue to focus on medtech growth investments

  • Venture
  • 22 April 2021
Paragon-backed Apontis Pharma announces IPO intention
Paragon-backed Apontis Pharma announces IPO intention

Paragon acquired the pharmaceutical business from its parent company UCB in 2018 via Paragon II

  • Investments
  • 21 April 2021
Hg's MeinAuto announces intention to float
Hg's MeinAuto announces intention to float

Hg invested in the new car sales platform in 2018; prior backers included HV Capital and DN Capital

  • Exits
  • 21 April 2021
343536
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013